Omnicell, Inc (OMCL) Files Form 4 Insider Selling : Jorge R. Taborga Sells 23,827 Shares

Omnicell, Inc (OMCL): Jorge R. Taborga , Executive VP. Engineering of Omnicell, Inc sold 23,827 shares on Apr 26, 2016. The Insider selling transaction was reported by the company on Apr 26, 2016 to the Securities and Exchange Commission. The shares were sold at $30.00 per share for a total value of $714,810.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 22, 2016, Dan S Johnston (EVP-Chief Legal & Admin Off) sold 8,850 shares at $27.42 per share price.On Feb 22, 2016, Jorge R. Taborga (Executive VP. Engineering) sold 1,685 shares at $27.42 per share price.Also, On Feb 10, 2016, J Christopher Drew (Executive VP, Field Operations) sold 15,000 shares at $27.57 per share price.On Dec 18, 2015, Nhat H Ngo (Exec. VP, Strategy & Bus Dev.) sold 4,069 shares at $28.71 per share price.

Omnicell: On Friday, Apr 22, 2016 heightened volatility was witnessed in Omnicell which led to swings in the share price. The shares opened for trading at $28.76 and hit $29.35 on the upside , eventually ending the session at $29.26, with a gain of 1.53% or 0.44 points. The heightened volatility saw the trading volume jump to 1,14,218 shares. The 52-week high of the share price is $40.8 and the company has a market cap of $1,048 M . The 52-week low of the share price is at $25.06.

Omnicell Money Flow Index Chart

Company has been under the radar of several Street Analysts.Omnicell is Reiterated by Topeka Capital Markets to Buy while Lowering the Price Target of the company shares to $ 37 from a previous price target of $38 . The Rating was issued on Mar 21, 2016.

Omnicell Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics and Medication Adherence. The Automation and Analytics segment is organized around the design manufacturing selling and servicing of medication and supply dispensing systems pharmacy inventory management systems and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards packaging equipment and ancillary products and services. The Company’s products include OmniRx SinglePointe AnywhereRN OptiFlex MS OptiFlex CL AccuFlex Autobond AutoGen and SureSeal among others.

Leave a Reply

Omnicell - Is it time to Sell?

Top Brokerage Firms are advising their investors on Omnicell. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.